Purchase Order 36C25024P1231
Award Date 7/3/24
Potential Completion Date 6/30/25
Potential Value $722K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Highland Beach, FL 33487, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. that specializes in innovative diagnostic imaging agents and targeted oncology therapies. The contract, valued at $124,296.48, was awarded by the Veterans Integrated Service Network 12 (VISN 12)...
- The Department of Veterans Affairs (VA) awarded a $538,099.28 firm-fixed-price delivery order contract to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., for the radiopharmaceutical product PYLARIFY (piflufolastat F-18). PYLARIFY is a diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract is not set aside and is part of a larger Blanket Purchase Agreement (BPA) valued at $5.5 million, which facilitates the...
- The U.S. Department of Veterans Affairs (VA) awarded a $649,736.50 firm fixed price delivery order contract to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract was awarded under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VA - VHA) awarded a $281,085.60 delivery order contract to Progenics Pharmaceuticals Inc., doing business as Progenics Pharmaceuticals and a division of Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc., for PYLARIFY (PIFLUFOLASTAT F-18). PYLARIFY is a radiopharmaceutical used in positron emission tomography (PET) imaging to visualize prostate-specific membrane antigen (PSMA) in men...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order to Progenics Pharmaceuticals Inc. (a division of Lantheus Medical Imaging, Inc.) for a decreased quantity of PYLARIFY Injection with a firm fixed-price contract ceiling of approximately $570K. The award, dated January 18, 2024, with an ultimate completion date of January 17, 2025, represents a modification to reduce the previously ordered quantity of this critical radiopharmaceutical. This...
- This federal contract award is for the delivery of PYLARIFY (piflufolastat F-18) injection, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract, valued at $607,856.24, was awarded to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA). The contract is a delivery order placed against the...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 (VA - VHA) awarded a $481,468.20 delivery order contract to Progenics Pharmaceuticals Inc. Lantheus Medical Imaging, Inc. Division - doing business as Progenics Pharmaceuticals, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract held by its parent company Lantheus Holdings, Inc. Lantheus Holdings, Inc. Division. The firm fixed price contract is to...
- This federal contract award was made by the Veterans Integrated Service Network 23 (VISN 23), a civilian agency that is part of the U.S. Department of Veterans Affairs (VA), to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico. The $200,255.59 firm-fixed-price delivery order contract is for the supply of radiopharmaceuticals and was not set aside for any specific business category. Pharmalogic Holdings Corp. is a for-profit organization that specializes in providing nuclear...
- The U.S. Department of Veterans Affairs (VA) awarded a firm fixed price delivery order contract to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract, valued at $328,671.99, has an ultimate completion date of July 4, 2023. Progenics Pharmaceuticals primarily provides...
- This is a firm fixed-price delivery order contract awarded to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The contract, valued at $1,466,705.44, is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract has an ultimate completion date of October 31,...